Aleksandra Drelich - Concepedia

Author

Aleksandra Drelich

The University of Texas Medical Branch at Galveston ORCID

Also Known As

A. Drelich, Aleksandra Drelich, Aleksandra K. Drelich, Alexandra Drelich, Conard, Alex, Hua Chen, Martinez, David R., Subramaniam, Sriram, Virginia P. Van Keulen, Virginia P. VanKeulen

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston Texas A&M University University of North Carolina at Chapel Hill Abound Bio (United States)University of Pittsburgh

About

Aleksandra Drelich is an author at The University of Texas Medical Branch at Galveston specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	502
2	Cell Biology	3	3	115
3	Health Sciences	1	1	32
4	Biochemistry	1	1	19
5	Biomolecular Engineering	1	1	45

Aleksandra Drelich

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models Wei Li, Alexandra Schäfer, Swarali S. Kulkarni, Cell Virus StructureViral EvolutionHigh PotencyViral PathogenesisImmunology	2020	128
A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors** Kai S. Yang, R. Xinyu, Yuying Ma, ChemMedChem	2020	128
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells Drake M. Mellott, Chien‐Te K. Tseng, Aleksandra Drelich, ACS Chemical Biology	2021	116
Bepridil is potent against SARS-CoV-2 in vitro Erol C. Vatansever, Kai S. Yang, Aleksandra Drelich, Proceedings of the National Academy of Sciences	2021	107
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection Wei Li, Chuan Chen, Aleksandra Drelich, Proceedings of the National Academy of Sciences	2020	92
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection <i>In Vitro</i> Francesca Curreli, Sofia M. Benedict Victor, Shahad Ahmed, mBio	2020	84
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L Anneliese S. Ashhurst, Arthur H. Tang, Pavla Fajtová, Journal of Medicinal Chemistry	2021	80
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection Qibin Geng, Wanbo Tai, Victoria K. Baxter, PLoS Pathogens VaccinationCross-protectionVaccine DevelopmentRbd VaccineSars-cov-2 Infection	2021	77
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering Jingen Zhu, Neeti Ananthaswamy, Swati Jain, Science Advances	2021	67
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold Zehua Sun, Chuan Chen, Wei Li, mAbs Viral DiagnosticsImmunologyViral PathogenesisMolecular BiologyLarge Library	2020	63

Page 1